Third, 55 men with PSA levels of 3 ng/mL or less in the experimental group had clinically significant prostate cancer detected during the first testing round in our study.11 If we assumed that some of those men had PSA levels of 3 ng/mL or greater in the second screening round, then this would affect the detection rate. Here, KLK3 is linked to prostate carcinoma.